JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 12, 2009, 10.2967/jnumed.109.063040
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.109.063040v1
50/7/1036    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruers, T. J.M.
Right arrow Articles by Oyen, W. J.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruers, T. J.M.
Right arrow Articles by Oyen, W. J.G.
Journal of Nuclear Medicine Vol. 50 No. 7 1036-1041
© 2009 by Society of Nuclear Medicine

doi: 10.2967/jnumed.109.063040

Clinical Investigation

Improved Selection of Patients for Hepatic Surgery of Colorectal Liver Metastases with 18F-FDG PET: A Randomized Study

Theo J.M. Ruers*,1, Bastiaan Wiering*,1, Joost R.M. van der Sijp2, Rudi M. Roumen3, Koert P. de Jong4, Emile F.I. Comans5, Jan Pruim6, Helena M. Dekker7, Paul F.M. Krabbe8 and Wim J.G. Oyen9

1 Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 2 Department of Surgical Oncology, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands; 3 Department of Surgery, Maxima Medical Center, Veldhoven, The Netherlands; 4 Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation at the University Medical Center Groningen, Groningen, The Netherlands; 5 Department of Nuclear Medicine and PET Research, Vrije Universiteit Medisch Centrum, Amsterdam, The Netherlands; 6 Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands; 7 Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 8 Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; and 9 Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Correspondence: For correspondence or reprints contact: Wim J.G. Oyen, Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail: w.oyen{at}nucmed.umcn.nl

With the increasing possibilities for surgical treatment of colorectal liver metastases, careful selection of patients who may benefit from surgical treatment becomes critical. The addition of PET to 18F-FDG may significantly improve conventional staging by CT. Up to now, definitive evidence that the addition of 18F-FDG PET to conventional staging leads to superior clinical results and improved clinical management in these patients has been lacking. In this randomized controlled trial in patients with colorectal liver metastases, we investigated whether the addition of 18F-FDG PET is beneficial and reduces the number of futile laparotomies. Methods: A total of 150 patients with colorectal liver metastases selected for surgical treatment by imaging with CT were randomly assigned to CT only (n = 75) or CT plus 18F-FDG PET (n = 75). Patients were followed up for at least 3 y. The primary outcome measure was futile laparotomy, defined as any laparotomy that did not result in complete tumor treatment, that revealed benign disease, or that did not result in a disease-free survival period longer than 6 mo. Results: Patient and tumor characteristics were similar for both groups. The number of futile laparotomies was 34 (45%) in the control arm without 18F-FDG PET and 21 (28%) in the experimental arm with 18F-FDG PET; the relative risk reduction was 38% (95% confidence interval, 4%–60%, P = 0.042). Conclusion: The number of futile laparotomies was reduced from 45% to 28%; thus, the addition of 18F-FDG PET to the work-up for surgical resection of colorectal liver metastases prevents unnecessary surgery in 1 of 6 patients.

Key Words: colorectal cancer • 18F-FDG-PET • liver metastases • staging • surgery

* Contributed equally to this work.

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2009 by the Society of Nuclear Medicine.